RBA Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,823
| Closed | -$391K | – | 93 |
|
|
2023
Q4 | $391K | Sell |
4,823
-375
| -7% | -$30.4K | 0.17% | 66 |
|
|
2023
Q3 | $390K | Sell |
5,198
-410
| -7% | -$30.7K | 0.19% | 64 |
|
|
2023
Q2 | $432K | Sell |
5,608
-179
| -3% | -$13.8K | 0.2% | 63 |
|
|
2023
Q1 | $480K | Sell |
5,787
-350
| -6% | -$29K | 0.24% | 61 |
|
|
2022
Q4 | $527K | Sell |
6,137
-178
| -3% | -$15.3K | 0.28% | 60 |
|
|
2022
Q3 | $390K | Sell |
6,315
-1,699
| -21% | -$105K | 0.22% | 62 |
|
|
2022
Q2 | $495K | Sell |
8,014
-795
| -9% | -$49.1K | 0.27% | 61 |
|
|
2022
Q1 | $524K | Sell |
8,809
-512
| -5% | -$30.5K | 0.25% | 64 |
|
|
2021
Q4 | $677K | Buy |
+9,321
| New | +$677K | 0.32% | 64 |
|
|
2021
Q2 | – | Sell |
-10,164
| Closed | -$657K | – | 131 |
|
|
2021
Q1 | $657K | Sell |
10,164
-450
| -4% | -$29.1K | 0.56% | 45 |
|
|
2020
Q4 | $618K | Sell |
10,614
-2,625
| -20% | -$153K | 0.37% | 70 |
|
|
2020
Q3 | $837K | Sell |
13,239
-2,413
| -15% | -$153K | 0.57% | 59 |
|
|
2020
Q2 | $1.2M | Sell |
15,652
-1,070
| -6% | -$82.3K | 0.88% | 45 |
|
|
2020
Q1 | $1.25M | Sell |
16,722
-1,327
| -7% | -$99.2K | 1.08% | 37 |
|
|
2019
Q4 | $1.17M | Sell |
18,049
-1,098
| -6% | -$71.1K | 0.8% | 45 |
|
|
2019
Q3 | $1.21M | Sell |
19,147
-1,181
| -6% | -$74.9K | 0.93% | 44 |
|
|
2019
Q2 | $1.37M | Sell |
20,328
-1,132
| -5% | -$76.5K | 1.06% | 44 |
|
|
2019
Q1 | $1.45M | Buy |
+21,460
| New | +$1.45M | 1.13% | 42 |
|